Page last updated: 2024-11-02

pd 98059 and Benign Cerebellar Neoplasms

pd 98059 has been researched along with Benign Cerebellar Neoplasms in 2 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sturla, LM1
Cowan, CW1
Guenther, L1
Castellino, RC1
Kim, JY1
Pomeroy, SL1
Chou, TT1
Trojanowski, JQ1
Lee, VM1

Other Studies

2 other studies available for pd 98059 and Benign Cerebellar Neoplasms

ArticleYear
A novel role for extracellular signal-regulated kinase 5 and myocyte enhancer factor 2 in medulloblastoma cell death.
    Cancer research, 2005, Jul-01, Volume: 65, Issue:13

    Topics: Animals; Apoptosis; Cell Line, Tumor; Cerebellar Neoplasms; DNA-Binding Proteins; Enzyme Inhibitors;

2005
A novel apoptotic pathway induced by nerve growth factor-mediated TrkA activation in medulloblastoma.
    The Journal of biological chemistry, 2000, Jan-07, Volume: 275, Issue:1

    Topics: Apoptosis; Butadienes; Caspases; Cerebellar Neoplasms; Flavonoids; Humans; Isoenzymes; Medulloblasto

2000